These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reduction of lipid and protein damage in patients with disorders of propionate metabolism under treatment: a possible protective role of L-carnitine supplementation. Ribas GS, Manfredini V, de Mari JF, Wayhs CY, Vanzin CS, Biancini GB, Sitta A, Deon M, Wajner M, Vargas CR. Int J Dev Neurosci; 2010 Apr; 28(2):127-32. PubMed ID: 20100562 [Abstract] [Full Text] [Related]
13. Prevention by L-carnitine of DNA damage induced by propionic and L-methylmalonic acids in human peripheral leukocytes in vitro. Ribas GS, Manfredini V, de Marco MG, Vieira RB, Wayhs CY, Vanzin CS, Biancini GB, Wajner M, Vargas CR. Mutat Res; 2010 Sep 30; 702(1):123-8. PubMed ID: 20659584 [Abstract] [Full Text] [Related]
17. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Roe CR, Hoppel CL, Stacey TE, Chalmers RA, Tracey BM, Millington DS. Arch Dis Child; 1983 Nov 30; 58(11):916-20. PubMed ID: 6651329 [Abstract] [Full Text] [Related]
18. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Ribas GS, Vargas CR, Wajner M. Gene; 2014 Jan 10; 533(2):469-76. PubMed ID: 24148561 [Abstract] [Full Text] [Related]
19. Profiling of oxidative stress in patients with inborn errors of metabolism. Mc Guire PJ, Parikh A, Diaz GA. Mol Genet Metab; 2009 Jan 10; 98(1-2):173-80. PubMed ID: 19604711 [Abstract] [Full Text] [Related]